Echo Therapeutics Income Tax

Echo Therapeutics's income tax stands at $500K as of September 2016. That compares with $-9.1M in the prior-year period — up 105.5% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Echo Therapeutics reported $500K in income tax versus $-9.1M a year earlier — a 105.5% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $-9.1M in the prior-year period — up 105.5% year over year. Sustained growth in income tax can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Echo Therapeutics's income tax evolved across reporting periods, while the comparison chart places ECTE next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.